UPMC ST MARGARET — History
CCN 390102 | 3-year financial timeline | COVID resilience: 24/100
🛡️ Public data only — no PHI permitted on this instance.
$249M
Latest Revenue (FY2022)
+0.8%
Revenue CAGR (3yr)
-21.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $244M | $240M | $249M | +3.4% | +0.8% |
| Operating Expenses | $256M | $277M | $301M | +8.8% | +8.6% |
| Operating Margin | -4.5% | -15.2% | -21.3% | -39.8% | +0.0% |
| Net Income | $-11M | $-37M | $-53M | -44.6% | +0.0% |
| Licensed Beds | 218 | 217 | 185 | -14.7% | -7.9% |
| Total Patient Days | 41,209 | 39,919 | 37,383 | -6.4% | -4.8% |
| Medicare Day % | 23% | 23% | 22% | -2.1% | -2.5% |
| Medicaid Day % | 1% | 1% | 0% | -26.2% | -22.4% |
COVID Impact & Recovery
Resilience Score: 24/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +1.7% ($244M → $249M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+0.8%
This Hospital
+7.6%
State Avg
Latest Margin
-21.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $251M | -29.7% |
| FY2024 (proj) | $253M | -38.0% |
| FY2025 (proj) | $255M | -46.4% |